Long-term Penn Research Across Disciplines Leads to the Development of a New ‘Patch’ that Uses Natural Body Motion to Fix Disc Herniation
A new biologic “patch” that is activated by a person’s natural motion has the potential to fix herniated discs in people’s backs, according to researchers at Penn Medicine and the CMC VA Medical Cente
Carisma Therapeutics Receives FDA Clearance of Investigational New Drug Application for CT-0525, a Novel CAR-M Cell Therapy
Having received a Study May Proceed notification from the FDA, Carisma plans to initiate a Phase 1 study in the months to come and to treat the first patient in the first half of 2024.
Penn’s Role in Philadelphia’s Rapidly Growing Life Sciences Industry
Technical.ly published an article about the future of the growth of the life sciences in Philadelphia, highlighting Penn’s role in the development of the city as a strong tech hub.
2023 PCI Ventures at Pennovation Works Showcase Puts Startup Growth and the Entrepreneurial Journey in the Spotlight
During the program, Kamna Giare-Patel, CEO of Cerespectus and Thomas H., CEO of Peroxitech, shared their startup journeys and discussed their companies.
Technical.ly State of the Philadelphia Tech Economy Report Highlights Innovation Accomplishments at Penn
According to the report, Penn ranked within the top five largest research & development expenditures of US universities in 2021.
ViTToria Biotherapeutics Raises Over $15 Million in Private Financing Round to Support the Development of Novel CAR-T Cell Therapy Lead Candidate, VIPER-101
ViTToria is focused on developing novel CAR-T cell therapies that transcend the limitations of current cell therapies.
Office of the Vice Provost for Research Provides Funding to 2023 Discovering the Future and Accelerating From Lab to Market Research Grant Recipients
The Office of the Vice Provost for Research has provided nearly $1 million in funding to support research through Discovering the Future and Accelerating From Lab to Market research grant programs.
Gov. Josh Shapiro, President Liz Magill, and others from the Penn community Celebrate the new Penn Institute for RNA Innovation
“One of our great strategic advantages is our compact and contiguous campus, where 12 amazing schools and a world-class health system coexist just a short walk from one another,” said Magill.
Vivodyne Raises $38 Million Seed Financing For Development of Lab Grown Human Tissue Platform
Penn spinout Vivodyne closed a $38 million seed funding round led by Khosla Ventures.
Mitchell Lab: Lipid nanoparticles that deliver mRNA to T cells show potential treatment for autoimmune diseases
The goal of this platform is to engineer adoptive cell therapies inside of the body for specific autoimmune diseases.